Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer

Vincenzo Serretta, Michele Battaglia, Paolo Verze, Estevao Lima, Riccardo Autorino, Matteo Ferro, Riccardo Schiavina, Gennaro Musi, Gilberto L. Almeida, Marco Borghesi, Antonio Cioffi, Gian Maria Busetto, Marco Borghesi, Giuseppe Ucciero, Mihai Dorin Vartolomei, Antonio Cioffi, Nicolae Crisan, Ettore De Berardinis, Rodolfo Hurle, Giorgio I. RussoChiara Scafuro, Abdal Rahman Abu Farhan, Marco Borghesi, Michele Battaglia, Francesco Cantiello, Daniela Terracciano, Sisto Perdonà, Ottavio De Cobelli, Deliu Victor Matei, Pierluigi Bove, Shahrokh F. Shariat, Savino M. Di Stasi, Giuseppe Morgia, Vincenzo Mirone, Rocco Damiano, Michele Battaglia, Giuseppe Lucarelli, Paolo Verze

Research output: Contribution to journalArticlepeer-review

22 Citations (Scopus)

Abstract

In this study, we defined a risk score (the SIM score) based on the measurement of routine systemic inflammatory markers. This score can identify patients with high-grade bladder cancer not invading the muscular layer who are more likely to suffer from tumor recurrence and progression. Therefore, the score could be used to select patients who might benefit from early bladder removal.
Original languageEnglish
Pages (from-to)403-410
Number of pages8
JournalEuropean urology oncology
Volume1
Publication statusPublished - 2018

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology
  • General Medicine

Fingerprint

Dive into the research topics of 'Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non-muscle-invasive Urothelial Bladder Cancer'. Together they form a unique fingerprint.

Cite this